Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Enveric Biosciences Inc | ENVB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.934 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.934 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.649 - 6.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.934 | USD |
Enveric Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.16M | 2.32M | - | 0 | -17.46M | -7.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Enveric Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENVB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.94 | 0.98 | 0.8558 | 0.9045893 | 117,183 | -0.006 | -0.64% |
| 1 Month | 1.02 | 1.19 | 0.83 | 1.01 | 257,778 | -0.086 | -8.43% |
| 3 Months | 0.7197 | 2.92 | 0.649 | 1.37 | 4,713,097 | 0.2143 | 29.78% |
| 6 Months | 1.89 | 2.92 | 0.649 | 1.36 | 2,221,016 | -0.956 | -50.58% |
| 1 Year | 1.60 | 6.98 | 0.649 | 2.55 | 2,010,518 | -0.666 | -41.63% |
| 3 Years | 2.35 | 14.87 | 0.1551 | 2.01 | 1,687,345 | -1.42 | -60.26% |
| 5 Years | 6.00 | 14.87 | 0.1551 | 2.61 | 2,069,811 | -5.07 | -84.43% |
Enveric Biosciences Description
| Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). |
